» Authors » Terrence F Blaschke

Terrence F Blaschke

Explore the profile of Terrence F Blaschke including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 688
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Blaschke T, Lumpkin M, Hartman D
Clin Pharmacol Ther . 2019 Nov; 107(1):68-71. PMID: 31773722
No abstract available.
12.
Cook L, Rose J, Alvey J, Jolley A, Kuhn R, Marron B, et al.
Neurol Neuroimmunol Neuroinflamm . 2019 Jul; 6(5):e583. PMID: 31355319
Objective: To develop a resource of systematically collected, longitudinal clinical data and biospecimens for assisting in the investigation into neuromyelitis optica spectrum disorder (NMOSD) epidemiology, pathogenesis, and treatment. Methods: To...
13.
Beekman J, Keisler A, Pedraza O, Haramura M, Gianella-Borradori A, Katz E, et al.
Neurol Neuroimmunol Neuroinflamm . 2019 Jul; 6(4):e580. PMID: 31355316
Objective: To gain insights into NMOSD disease impact, which may negatively affect QoL of patients, their families, and social network. Methods: The current study used validated instruments to assess physical,...
14.
Insel P, Amara S, Blaschke T, Meyer U
Annu Rev Pharmacol Toxicol . 2019 Jan; 59:15-20. PMID: 30625286
"New Therapeutic Targets" is the theme of articles in the Annual Review of Pharmacology and Toxicology, Volume 59. Reviews in this volume discuss targets for a variety of conditions in...
15.
Insel P, Amara S, Blaschke T, Meyer U
Annu Rev Pharmacol Toxicol . 2017 Oct; 58:33-36. PMID: 29058990
The theme "New Approaches for Studying Drug and Toxicant Action: Applications to Drug Discovery and Development" links 13 articles in this volume of the Annual Review of Pharmacology and Toxicology...
16.
Blaschke T
Clin Pharmacol Ther . 2017 Oct; 47 Suppl 2:270-272. PMID: 29023662
No abstract available.
17.
Haberer J, Sabin L, Amico K, Orrell C, Galarraga O, Tsai A, et al.
J Int AIDS Soc . 2017 Jun; 20(1):21371. PMID: 28630651
: Successful population-level antiretroviral therapy (ART) adherence will be necessary to realize both the clinical and prevention benefits of antiretroviral scale-up and, ultimately, the end of AIDS. Although many people...
18.
Breckenridge A, Aronson J, Blaschke T, Hartman D, Peck C, Vrijens B
Nat Rev Drug Discov . 2017 Feb; 16(3):149-150. PMID: 28154411
Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this article,...
19.
Insel P, Amara S, Blaschke T, Meyer U
Annu Rev Pharmacol Toxicol . 2016 Oct; 57:13-17. PMID: 27732830
Major advances in scientific discovery and insights can result from the development and use of new techniques, as exemplified by the work of Solomon Snyder, who writes a prefatory article...
20.
Insel P, Amara S, Blaschke T, Meyer U
Annu Rev Pharmacol Toxicol . 2015 Nov; 56:19-22. PMID: 26551200
No abstract available.